Bizarre Patents
Mouthguard made at least partially from an edible candy
A mouthguard includes a U-shaped upper bite plate which removably fits over upper teeth of a person, with the entire upper bite plate being made from a soft, deformable and edible gummi candy.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7834064 | Clinical method for the immunomodulatory and vaccine adjuvant use of poly-ICLC and other dsRNAs An improved understanding and method for the clinical adjuvant and immunomodulatory use of dsRNAs and ply-ICLC in particular, alone or in conjunction with other drugs and various vaccines designed to prevent or treat various microbial, viral, neoplastic, autoimmune ... | 11/16/2010 |
| 7229614 | Interferon gamma in the detection and treatment of angiomyolipomas The present invention is directed to methods of treating or preventing angiomyolipomas by administering interferon gamma. It also encompasses methods for assessing the risk of a patient developing angiomyolipomas based upon interferon gamma expression. ... | 06/12/2007 |
| 6656924 | Immunopotentiating compositions The invention provides an immunopotentiating composition and to a composition accelerating the production of interferon-γ, both comprising lactosuclose as an active ingredient. In particular, the invention provides such compositions in the form of a food... | 12/02/2003 |
| 6455060 | S(+) desmethylselegiline and its use to treat immune system dysfunction The present invention provides novel compositions and methods for using the S(+) enantiomer of desmethylselegiline (N-methyl-N-(prop-2-ynyl)-2-aminophenylpropane), for the treatment of selegiline-responsive diseases and conditions. Diseases and conditions... | 09/24/2002 |
| 6410034 | Dermal absorption-promoting agent A dermal absorption-promoting agent comprising p-methane-3,8-diol and 1,3-butylene glycol as well as a topical formulation containing the same; and a dermal absorption-promoting agent further comprising 1,3-butylene glycol, as well as a topical formulatio... | 06/25/2002 |
| 6365166 | Gel formulations for topical drug delivery Pharmaceutical gel formulations for topical drug delivery include drug, colloidal silicon dioxide, triacetin and, preferably, propylene glycol. The gel formulations are well suited for topical delivery of the drug 4-amino-2-ethoxymethyl-,-di... | 04/02/2002 |
| 6337325 | Combined preparation for the therapy of immune diseases A combination preparation comprising a compound which has a phosphodiesterase-inhibiting action, and a compound which reduces the biologically effective intracellular Ca2+ content, is suitable for the treatment of immunological diseases.... | 01/08/2002 |
| 6221893 | Administration of histamine for therapeutic purposes Methods for obtaining beneficial stable levels of circulating histamine are disclosed for use in methods for enhancing natural killer cell cytotoxicity. In such methods, a beneficial level of circulating histamine is attained and an agent whose ability to... | 04/24/2001 |
| 6083534 | Pharmaceutical compositions for controlled release of soluble receptors A controlled release pharmaceutical composition includes a biocompatible polymeric material, preferably polyethylene-vinyl acetate or poly(lactic-glucolic acid), having incorporated therein a soluble receptor capable of binding to its ligand and thus affe... | 07/04/2000 |
| 6080782 | Cyclohexyl dihydrobenzofuranes Compounds of formula I are selective cyclic nucleotide phosphodiesterase (PDE) inhibitors (namely of type IV). They and pharmaceutical compositions in which they are active ingredients are useful as bronchial therapeutics, for elimination of erectile dysf... | 06/27/2000 |
| 6063373 | Enhanced activation of NK cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitor An improved method for the prevention of the inactivation of natural killer (NK) cells and the enhanced activation of NK cells in the presence of monocytes using a combination of a natural killer cell activator and a compound effective to inhibit the prod... | 05/16/2000 |
| 6024983 | Composition for delivering bioactive agents for immune response and its preparation A method, and compositions for use therein capable, of delivering a bioactive agent to an animal entailing the steps of encapsulating effective amounts of the agent in a biocompatible excipient to form microcapsules having a size less than approximately t... | 02/15/2000 |
| 5990103 | Combination preparation for use in immunological diseases A combination preparation comprising a compound which has a phosphodiesterase-inhibiting action, and a compound which reduces the biologically effective intracellular Ca2+ content, is suitable for the treatment of immunological diseases.... | 11/23/1999 |
| 5976569 | Diketopiperazine-based delivery systems Compositions useful in the delivery of active agents are provided. These delivery compositions include (a) an active agent; and either (b)(1) a carrier of (i) at least one amino acid and (ii) at least one diketopiperazine or (b)(2) at least one mono-N-sub... | 11/02/1999 |
| 5952313 | LPS antagonists and methods of making and using the same Compositions for antagonizing gram negative bacterial endotoxic activity. Methods of antagonizing gram negative bacterial endotoxic activity. Methods of treating septic or toxic shock in a patient. Methods of treating or preventing a lipopolysaccharide me... | 09/14/1999 |
| 5876703 | Flavanonol derivatives and hair-nourishing, hair-growing compositions containing the derivatives The present invention relates to flavanonol derivatives represented by formula (1): ##STR1## (wherein R1 represents an alkyl group, and each of R2 and R3 represents a hydrogen atom, an alkyl group which may have a ... | 03/02/1999 |
| 5863905 | 2',5'-phosphorothioate/phosphodiester oligoadenylates and anti-viral uses thereof Optically active antiviral compounds having the formula ##STR1## wherein m is 0, 1, 2, or 3; n and q are selected from the group of 0 and 1, provided that n and q may not both be zero; and R, R1, and R2 are independently of each... | 01/26/1999 |
| 5679644 | Methods of treating diseases using triterpenoid acid derivatives Triterpenoid acid derivatives are described that exhibit dual pharmacophobic activities, specifically selectin ligand and leukotriene biosynthetic inhibitory activities, and that thus have significant applications for the treatment or prevention of certai... | 10/21/1997 |
| 5624938 | Use of chloroquine to treat multiple sclerosis This invention provides a pharmaceutical composition which comprises an amount of chloroquine effective to block MHC Class I recycling and an amount of a CD8+ T cell stimulatory agent effective to stimulate proliferation of CD8+ T cells to a concentration... | 04/29/1997 |
| 5620703 | Stimulating hematopoietic activity with carboplatin or lobaplatin A process for stimulating hematopoietic activity in animals which comprises administering to a patient in need therefor a therapeutically effective amount of an agent containing as its active ingredient a water-soluble or lipid-soluble transition metal co... | 04/15/1997 |
| 5556840 | 2',5'-phosphorothioate oligoadenylates as anitiviral agents Optically active compounds of the formula ##STR1## wherein n is 1 or 2 and m is 0, 1, 2 or 3 have antiviral activity. Compounds of the formula wherein at least one of the internecleotide phosphorothioate linkages is of the Sp configuration possess in... | 09/17/1996 |
| 5550111 | Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof Viral infection is inhibited in mammals by administration of metabolically stable, non-toxic 2', 5'-oligoadenylate (2-5A) derivatives that have a dual therapeutic effect. The compounds activate the intracellular latent 2-5A dependent endoribonuclease RNas... | 08/27/1996 |
| 5514661 | Immunological activity of rhamnolipids Methods for treating various autoimmune diseases and for providing immunorestoration, by administering, to a subject in need thereof, an effective amount of a composition having, as active ingredient, one or more rhamnolipids of formula (I) ##STR1## ... | 05/07/1996 |
| 5512290 | Compositions containing 2-acetyl-1-pyrroline A powder-form composition of 2-acetyl-1-pyrroline incorporated with a support of maltodextrin and/or cyclodextrin. The composition is prepared by hydrolyzing a 2-(1-alkoxyethenyl)-1-pyrroline with an acid to obtain a reaction medium, adding an equimolar a... | 04/30/1996 |
| 5496810 | Pyrimidine deoxyribonucleoside potentiation of combination therapy based on 5-fluorouracil and interferon The applicants have discovered a method of treating malignancies which comprises administering effective amounts of 5-fluorouracil, interferon- and a compound formula (I): ##STR1## wherein R is selected is selected from the group consisting of... | 03/05/1996 |
| 5466675 | Immunological activity of rhamnolipids Methods for treating various autoimmune diseases and for providing immunorestoration, by administering, to a subject in need thereof, an effective amount of a composition having, as active ingredient, one or more rhamnolipids of formula (I) ##STR1## ... | 11/14/1995 |
| 5409905 | Cure for commond cold Present invention is a non-toxic, flavor stable, pleasant tasting composition releasing Zn2+ from compositions containing a highly ionizable zinc compound other than zinc gluconate that reduces the duration of common colds in humans. The compos... | 04/25/1995 |
| 5348739 | Combined anti-tumor therapy with interleukin-2 and histamine, analogs thereof or H2 -receptor agonists A method of inhibiting the development of malignant tumors and the formation of metastases of malignant tumor cells in a subject carrying the comprises administering to the subject IL-2 and an agent selected from the group consisting of histamine, a hista... | 09/20/1994 |
| 5288704 | Synergistic composition comprising a fibroblast growth factor and a sulfated polysaccharide, for use as antiviral agent A pharmaceutcial composition is provided for use in the prevention or treatment of viral infections caused by enveloped viruses. The composition comprises a fibroblast growth factor, a sulfated polysaccharide with antiviral activity, and one or more pharm... | 02/22/1994 |
| 5209920 | Evaluative means for detecting inflammatory reactivity Inbred Lewis (LEW/N) female rats develop an arthritis in response to Group A streptococcal cell wall peptidoglycanpolysaccharide (SCW) which mimics human rheumatoid arthritis. Histocompatible Fischer (F344/N) rats, on the other hand, do not develop arthri... | 05/11/1993 |
| 5157024 | Method of enhancing the activity of phagocytes including macrophages, modulating the cellular or humoral immune response, and reducing the adverse effects of stress in warm blooded animals In one variant, the invention provides a method of enhancing the activity of phagocytes including macrophages, and in a further variant, a method of modulating the cellular or humoral immune response to warm blooded animals. The invention also provides a ... | 10/20/1992 |
| 5124145 | Method for the prevention and treatment of bovine mastitis A method for treating or preventing mastitis in cows is disclosed. The method contemplates the intramammary injection of bovine interferon-gamma. Interferon-gamma can be administered prior to infection to effectively suppress the rate, severity, and durat... | 06/23/1992 |
| 5104650 | Uses of recombinant colony stimulating factor-1 A colony stimulating factor, CSF-1, is a lymphokine useful in overcoming the immunosuppression induced by chemotherapy or resulting from other causes. CSF-1 is obtained in usable amounts by recombinant methods, including cloning and expression of the muri... | 04/14/1992 |
| 5093116 | Method of treating viral infection utilizing inteferon and pipyridamole A method of enhancing the antiviral activity of IFN- and especially human IFN- is disclosed which comprises administration of Dipyridamole or a pharmaceutically acceptable salt thereof to a subject receiving IFN-. Also disclosed are p... | 03/03/1992 |
| 5071872 | Method for improving interleukin-2 activity using aci-reductone compounds A method for improving interleukin-2 induced lymphocyte killing of cancer cells comprises administering to a patient having cancer an effective amount of at least one aci-reductone compound containing a --C(OH).dbd.C(OH)--C.dbd.O redox functionality or a ... | 12/10/1991 |
| 5063209 | Modulation of aids virus-related events by double-stranded RNAs The use of mismatched dsRNA, e.g., AMPLIGEN.RTM. for the manufacture of compositions for use in the selective activation of a latent natural defense system within human cells, both cells already infected with AIDS virus as well as cells at risk to infecti... | 11/05/1991 |
| 5017587 | Treatment of plantar warts using cycloheximide The invention consists in healing of plantar warts with cycloheximide. Cycloheximide is used in various topical forms and methods of application to treat plantar warts. The concentrations employed ranges from 0.01% to 5.0% and the duration of treatment fr... | 05/21/1991 |
| 5001119 | 16-substituted androstanes and 16-substituted androstenes Compounds of the formula: ##STR1## are useful as anti-cancer, anti-obesity, anti-diabetic, anti-coronary agents, anti-aging agents, anti-hypolipidemic agents and anti-autoimmune agents.... | 03/19/1991 |
| 4937327 | Derivative of D.25, process for its preparation, its use as an immunostimulant, and pharmaceutical compositions containing the derivative The present invention relates to a polysaccharide derivative, which is a derivative of D.25 in which the galactofuranose (Galf) residues of the linear polysaccharide chain have been converted at least partly to arabinose. It also relates to the... | 06/26/1990 |
| 4933440 | Immunomodulators obtained semisynthetically from a bacterial polysaccharide isolated from a non-encapsulated mutant strain of Klebsiella pneumoniae The invention relates to a polysaccharide derivative which is an amide, an ester, an ether, a salt or a quaternary ammonium derivative of D.25 with an amine, an acid or an alcohol.... | 06/12/1990 |
